Related Experiment Video
Updated: May 1, 2026
10:24
Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
Published on: September 19, 2019
5.5K
Comparing stochastic differential equations and agent-based modelling and simulation for early-stage cancer
Grazziela P Figueredo1, Peer-Olaf Siebers1, Markus R Owen2
1School of Computer Science, The University of Nottingham, Nottingham, United Kingdom.
Plos One
|April 23, 2014
Summary
Agent-based modeling and simulation (ABMS) offers advantages over ordinary differential equation (ODE) models for studying cancer-immune interactions. ABMS captures individual behaviors and memory, revealing emergent patterns missed by traditional methods like the Gillespie algorithm.
Area of Science:
- Computational biology
- Mathematical oncology
- Systems immunology
Background:
- Ordinary differential equation (ODE) models are limited in capturing stochasticity and individual behaviors in biological systems.
- Agent-based modeling and simulation (ABMS) presents an alternative paradigm for simulating complex biological interactions.
- Investigating early-stage cancer and immune system dynamics requires robust modeling approaches.
Purpose of the Study:
- To compare the efficacy of agent-based modeling and simulation (ABMS) against stochastic ordinary differential equation (ODE) models, specifically the Gillespie algorithm.
- To determine if ABMS and stochastic ODE formulations yield similar results for early-stage cancer-immune interactions.
- To assess the interchangeability and potential benefits of ABMS compared to the Gillespie algorithm in simulating these dynamics.
Main Methods:
- Re-conceptualized three established mathematical models of tumor-immune interactions from an agent-based perspective.
- Converted these models to the Gillespie algorithm formulation for comparative analysis.
- Focused on methodological comparison of simulation approaches rather than biological insights.
Main Results:
- Equivalent models implementing the same mechanisms can be developed using both ABMS and the Gillespie algorithm.
- The Gillespie algorithm's inability to retain individual memory impacts result similarity compared to ABMS.
- ABMS revealed emergent system behaviors not observed with the Gillespie algorithm.
Conclusions:
- ABMS provides a more comprehensive approach to modeling cancer-immune interactions by capturing individual memory and emergent behaviors.
- While stochastic ODEs can replicate some mechanisms, they may not fully capture the system's complexity compared to ABMS.
- Methodological choices in simulation significantly influence the observed patterns and outcomes in cancer immunology research.
More Related Videos
13:34A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
9.5K
09:53Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
Published on: August 16, 2020
6.4K
Related Concept Videos
01:25Modeling with Differential Equations
334
Population dynamics can be described mathematically by considering the population size P(t) as a function of time. The rate of change of the population is then represented by the derivative of P(t). A simple assumption is that the rate of growth is proportional to the size of the population itself. This leads to an exponential growth model, where the population increases rapidly without bound. While this is a useful first approximation, it does not reflect realistic long-term...
334
01:21Cancer Survival Analysis
863
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
863
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
02:43Mouse Models of Cancer Study
4.7K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
4.7K
01:20Comparing the Survival Analysis of Two or More Groups
712
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
712
01:27Pharmacodynamic Models: Overview
159
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
159